Discrete Semiconductor Market Forecasts to 2028 – Global Analysis By Type (Thyristors, Transistors, Modules, Diodes), Component (Logic Devices, Memory Devices, Discrete Power Devices), End User (Consumer Electronics, Industrial, Automotive, Communication, Networking) and Geography
According to Stratistics MRC, the Global Lab Automation Software Market is accounted for $13,760 million in 2022 and is expected to reach $22,201 million by 2028 growing at a CAGR of 8.3% during the forecast period. Lab automation software is an effective tool that aids in standardising real-time analysis while removing specialised data handling, which is frequently prone to error.
According to NIH (National Institutes for Health), Human genome funding by the NIH was around 4.43 billion U.S. dollars in 2021, which is estimated at 4.55 billion U.S. dollars in 2022. According to India Brand Equity Foundation (IBEF), pharmaceutical companies invested 8.8% of their sales in R&D.
Market Dynamics:
Driver:
Increasing R&D investments in pharmaceuticals
Biotechnology as well as pharmaceutical companies is majorly investing in research and development to gather the rising requirements of health care sector. Furthermore, collaborations and partnerships among stakeholders of healthcare and pharma companies for research and development interested in therapeutics will encourage lab automation software.
Restraint:
Slow adoption of automation among SMEs laboratories
Owing to funds limitation, various small and medium sized laboratories are finding it complicated to choose lab automation software. The high preservation as well as service costs related to laboratory informatics solutions structures a main restraint.
Opportunity:
Improving healthcare infrastructure across emerging countries
Makers and distributors of Lab Automation Software products are anticipated to benefit significantly from emerging markets. Increased sales of lab automation products are a result of the rising demand for clinical diagnostic processes. Major product manufacturers are expanding their distribution networks and manufacturing capacities to increase their penetration into emerging markets.
Threat:
Limited feasibility with technology integration in analytical labs
The difficulties in transferring data and establishing communication standards across automated instruments, the evolving nature of laboratory work necessitates automated systems with increased flexibility and interface capabilities. This makes lab automation difficult. Providing solutions that are interoperable with other laboratory systems is a significant problem for providers of lab automation solutions.
Covid-19 Impact
Diagnostic laboratories have had to scale up services and increase testing capabilities in response to COVID-19, which has increased the pressure on both physical infrastructure and data management systems. Expanding digital operations without extending high-throughput testing capabilities might restrict the benefits automation brings and perhaps affect the reliability of outcomes. The COVID-19 pandemic has increased pressure on pharma and clinical labs while also stepping up drug discovery and research activities.
The laboratory information management system segment is expected to be the largest during the forecast period
The laboratory information management system segment is estimated to have a lucrative growth, due to rise in sample volumes, demand for diagnostic testing from the growing aged population, increasing pressure to fulfil with regulations, mounting necessitate integrating healthcare systems, a move from legacy systems to commercial off-the-shelf LIMS solutions, in addition to technological advancements in LIMS products. Furthermore, the financial support for tests, leads to a boost in laboratory information and data.
The Clinical Diagnostics segment is expected to have the highest CAGR during the forecast period
The Clinical Diagnostics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to developments in technology, a rise in the number of automated systems being supplied by market players, and a rise in the utilisation of automated systems as a result of advantages including lowered contamination risk and elimination of human error. By automating clinical diagnostic facilities, staff handling of biological samples, particularly sample transport, sub sampling, analytical processes, and waste management, is reduced.
Region with highest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to quick growth in the pharmaceuticals market in this region. The expansion can be attributed to the improved investment in pharmaceutical research and development. In addition, Asia Pacific region is model for conducting pharmaceutical research due to the great team of heterogeneous population groups, distinct other continents. This region is considered the most preferred to outsource pharmaceutical research, owing to the availability of skilled labour and lower cost required to develop drugs.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to obtain more research contracts, businesses are moving toward CRO (contract research organisation) partnerships, which have benefitted this region the most. Drug companies are choosing automated lab software that can decrease the errors, cost, and time associated with the discovery of the drug because time and money are the two most important considerations for development. The robust economic performance that permits major upgrading and investments in new technologies may be the primary cause of the large proportion of the aforementioned regional category.
Key players in the market
Some of the key players profiled in the Lab Automation Software Market include Danaher Corporation, Synchron Lab Automation, Siemens Healthineers AG, Perkinelmer Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Eppendorf AG, Green Scientific Labs Holdings Inc., Biosero, Scispot, Veeva Vault LIMS, Promium, L.L.C., Lab Vantage Solutions, Honeywell International, Roche Holding AG, Agilent Technologies, Hudson Robotics, Aurora Biomed, Becton Dickinson and Tecan Group Ltd.
Key Developments:
In July 2022, Green Scientific Labs Holdings Inc. has launched a laboratory information management system (LIMS) for immediate use across all its laboratory operations. The company's proprietary LIMS technology has a robust set of cutting-edge features, including Artificial Intelligence to provide compliance with state regulations on COAs, real-time turnaround time (TAT) tracking to identify bottlenecks and to provide industry-leading testing times, digital batch downloading, and real time audit logs that compile a record of events and changes within the software.
In March 2022, Biosero has launched several new products and features in its Green Button Go software suite. These products work together to provide a range of advanced capabilities that help customers streamline, control, and generate better results from their automated lab systems. Green Button Go software from Biosero enables scientists to automate workflows ranging from a single workstation to operations spanning multiple labs.
In September 2021, Veeva Vault LIMS is a new cloud application from Veeva Systems designed to modernize quality control (QC) lab operations. By incorporating Vault LIMS into Veeva Vault Quality Suite, manufacturing organizations can seamlessly connect their lab operations with the broader quality ecosystem. This will speed up the batch release and lower inventory costs by streamlining sample management, test execution, and lab investigation processes.
In July 2021, LabVantage Solutions, Inc has launched the 8.7 edition of its flagship LabVantage LIMS designed to provide a secure self-service web portal for the lab’s external clients. With the upgraded LabVantage LIMS 8.7, customers can extend appropriate access rights outside the laboratory via the Portal while protecting their valuable and sensitive data, eschewing the need for manual requests for tests and other services.
Softwares Covered:
• Chromatography Data System (CDS)
• Laboratory Information Management System (LIMS)
• Laboratory Information System (LIS)
• Scientific Data Management System (SDMS)
• Electronic Lab Notebook (ELN)
• Other Softwares
Applications Covered:
• Proteomics
• Drug Discovery and Development
• Clinical Diagnostics
• Genomics
• Other Applications
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook